Skip to content

The effect of gonadotropin agonist on uterine myoma

Effect of gonadotropins on the onset of postoperative hysteroscopic hemorrhage in patients with bleeding and uterine myoma .

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017111423949N6
Enrollment
46
Registered
2017-11-19
Start date
2017-11-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

leiomyoma of uterus. Submucous leiomyoma of uterus

Interventions

Intervention 1: Type of intervention in the intervention group: Gonadotrophin agonist injection. Intervention 2: There is no intervention in the control group.
Treatment - Drugs
Type of intervention in the intervention group: Gonadotrophin agonist injection.

Sponsors

Vice chancellor for research, Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Entry Requirements: Patients with abnormal hemorrhage present in a submucosal ultrasonography referring to the clinic of the Rasoul Hospital and who are candidates for myomectomy hysteroscopy are included in the study. Exclusion criteria:Thyroid disease; Cancer history; Coagulation disorders; Abnormal pap smear; vascular disease; High prolactin

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recurrence uterine myoma. Timepoint: pre operation and 3 m after operation. Method of measurement: ultrasonography.

Secondary

MeasureTime frame
Hemoglubin drop. Timepoint: preoperation and 6 hours after operation. Method of measurement: CBC.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Banafshe Tajbakhsh

Iran University of Medical Science

tajviolet@gmail.com+98 21 2562

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026